Screener
Novavax NVAX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts receivable, prepaid expenses, and other assets | 95,116 | (94,947) |
| Accounts payable, accrued expenses, and other liabilities | (97,170) | (274,488) |
| Deferred revenue | (55,664) | (608,860) |
| Net cash used in operating activities | (105,230) | (312,964) |
| Investing Activities: | ||
| Capital expenditures, including internal-use software | (1,858) | (2,122) |
| Proceeds from assets held for sale | 39,750 | — |
| Purchases of marketable securities | (295,820) | (114,724) |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's operating cash flow?
- Novavax (NVAX) reported operating cash flow of -$72.81M in Q2 2026.
- How has Novavax's operating cash flow changed year-over-year?
- Novavax's operating cash flow increased by 42.9% year-over-year, from -$127.46M to -$72.81M.
- What is the long-term trend for Novavax's operating cash flow?
- Over 2 years (2022 to 2024), Novavax's operating cash flow has grown at a -54.2% compound annual growth rate (CAGR), from -$415.94M to -$87.26M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Novavax's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude